Results from the phase 3 PAPILLON study show that first-line amivantamab plus carboplatin-pemetrexed (amivantamab-chemotherapy) was associated with numerically longer overall survival compared with chemotherapy in patients ...
Sep 13, 2026
0
5
An international research team that included Martín Hugo, a Serra Húnter lecturer in the Department of Biochemistry and Molecular Biology at the UAB, has described how two opposing chemical modifications of proteins, sulfenylation ...
Sep 13, 2026
0
5
An exploratory 8-year landmark update from the Phase III ADAURA trial showed that adjuvant osimertinib continued to provide a long-term overall survival benefit for patients with completely resected, EGFR-mutated stage IB–IIIA ...
Sep 13, 2026
0
3
First-line treatment with trastuzumab deruxtecan (T-DXd) significantly improved progression-free survival compared with pembrolizumab plus platinum-based chemotherapy in patients with advanced or metastatic HER2-mutant non-small ...
Sep 13, 2026
0
3
New blood tests that might predict Alzheimer's years before symptoms begin may sound tantalizing for people who worry about later-in-life dementia. But doctors say they aren't quite ready yet—and besides, you don't need a ...
Sep 13, 2026
0
23
More than 7,000 Ebola cases have been recorded in the Democratic Republic of Congo's worst-ever outbreak of the deadly disease, according to figures released Saturday by Congolese authorities.
Sep 13, 2026
0
8
Adding zipalertinib to platinum-pemetrexed chemotherapy significantly improved progression-free survival in patients receiving first-line treatment for advanced non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion ...
Sep 13, 2026
0
6
A 40-year-old woman in Pennsylvania has died of measles, authorities said Sunday, bringing this year's death toll from the highly contagious, preventable disease to three amid declining vaccination rates.
Sep 13, 2026
0
11
Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments. A new AI tool called ...
Cystic fibrosis, one of the most common genetic diseases in Switzerland, promotes chronic bacterial infections by impairing the protective barrier of the airways. Scientists at the University of Geneva (UNIGE) have discovered ...
Sep 12, 2026
0
31
